Literature DB >> 4790833

Specific "arming" of normal lymph-node cells by sera from tumor-bearing mice.

S Pollack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790833     DOI: 10.1002/ijc.2910110116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  The protective effect of antisera against leukaemia in vivo--a reappraisal.

Authors:  P Hersey
Journal:  Br J Cancer Suppl       Date:  1973-08

2.  Complex arming in antibody-dependent cell-mediated cytotoxicity: ultrastructural studies of the interaction between human effector cells armed with aggregated anti-DNP antibody and DNP-coated erythrocytes.

Authors:  P L Penfold; L C Walker; I M Roitt
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

3.  Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.

Authors:  L Walker; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

4.  Effect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth.

Authors:  F Guiliani; A M Casazza; C Soranzo; A Di Marco
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

5.  Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity.

Authors:  A Mantovani; N Polentarutti; G Alessandri; A Vecchi; F Giuliani; F Spreafico
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640

6.  Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

Authors:  K J Pennline; S B Evans; J F Nawrocki; J C Rees; C S Johnson; D A Vallera; M C Dodd
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

7.  Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.

Authors:  C Basham; G A Currie
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.